Recently Viewed

Clear All
  • Home
  • Stories
  • News Announcement
  • Parmax Pharma: Receipt Of ''In-Principle'' Approval Under Regulation 28(1) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For Issuance Of Equity Shares And Warrants On Preferential Basis
News Announcement

Parmax Pharma: Receipt Of ''In-Principle'' Approval Under Regulation 28(1) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For Issuance Of Equity Shares And Warrants On Preferential Basis

22-Aug-2026 Follow Value Research Online on Google download pdfDownload PDF Parmax Pharma

Receipt of In Principle Approval

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan